Workflow
人民健康公众微信号
icon
Search documents
直播预告:孩子得了血管瘤怎么办?专家为您说清楚
Ren Min Wang· 2025-11-25 02:43
吉毅,四川大学华西医院小儿外科主任医师、医学博士、教授、博士研究生导师。担任中华医学会 小儿外科分委会全国委员、中华医学会小儿外科分委会肿瘤学组副组长、中华医学会整形外科分委会血 管瘤与脉管畸形学组委员、小儿矫形学组委员等学术职务。 如何收看直播: 嘉宾简介: 血管瘤与脉管畸形是婴幼儿时期最常见的先天性良性肿瘤或血管病变,虽多为良性,但其生长位 置、类型及并发症,常给患儿家庭带来巨大的困惑与心理压力。 11月26日10:00至11:00,四川大学华西医院小儿外科主任医师吉毅教授做客"人民好医生"客户端直 播间,为您深入讲解血管瘤与脉管畸形的科学区分、发病特点、最新治疗手段及家庭护理要点等核心问 题,旨在引导家长正确应对,把握最佳干预时机,为孩子们的健康成长保驾护航。 一、下载人民好医生App,点击"名医直播"进入栏目进行收看。 更多贴心易懂的健康科普,三甲名医直播互动,请关注人民好医生APP 二、关注人民健康公众微信号(微信号:rmwjkpd),右下角点击健康互动 "下载人民好医生 App",下载后进入客户端收看。 重要提示:人民好医生客户端只提供疾病科普,不做具体诊断和开处方。若身体不适请及时就医。 ...
直播预告:糖尿病视网膜病变“早筛早诊早治”
Ren Min Wang· 2025-11-13 05:00
Core Points - Diabetic Retinopathy (DR) is the leading cause of blindness among working-age individuals in China, representing a significant microvascular complication of diabetes [1] - The disease often progresses silently without noticeable symptoms in its early stages, leading to irreversible vision damage by the time patients notice vision decline [1] Group 1: Event Details - A live broadcast will be held on November 14 from 10:00 to 11:00, featuring Wang Zhiqiang, the Director of the Ophthalmology Department at Beijing University of Chinese Medicine Third Affiliated Hospital [1] - The session aims to educate on constructing a comprehensive management strategy from systemic to ocular health to effectively curb the progression of DR and protect the visual health and quality of life of diabetic patients [1] Group 2: Guest Profile - Wang Zhiqiang holds multiple academic positions, including Director of the Ophthalmology Department and various leadership roles in ophthalmology associations [5] Group 3: Viewing Instructions - To watch the live broadcast, users need to download the "People's Good Doctor" app and enter the "Famous Doctor Live" section [6] - Additional health education content can be accessed through the People's Health public WeChat account [8]
直播预告:神经纤维瘤病的精准治疗与新希望
Ren Min Wang· 2025-09-15 07:50
Core Viewpoint - Neurofibromatosis (NF) is a genetic tumor syndrome affecting the nervous system, characterized by symptoms such as café-au-lait spots, hearing loss, and physical lumps, significantly impacting patients' quality of life. Current treatment primarily involves surgery, which is challenging and risky, leading to a demand for more effective therapies [1]. Group 1: Expert Insights - Li Wenbin, the director of the Tumor Comprehensive Treatment Center at Beijing Tiantan Hospital, is a key expert in the field, specializing in the comprehensive treatment of neuro-oncological conditions, including gliomas and brain metastases [2]. - Li Wenbin has been involved in two national key innovative drug Phase I clinical trials, indicating a focus on advancing treatment options for neurofibromatosis and related conditions [2]. Group 2: Live Broadcast Information - The live session featuring Li Wenbin will take place on September 16 from 14:00 to 15:00, providing insights into the scientific understanding of neurofibromatosis, the latest treatment methods, and standardized interventions [1]. - Viewers can access the live broadcast by downloading the People's Good Doctor App and navigating to the "Famous Doctor Live" section [3].